Cargando…

Smell and Taste in Inflammatory Bowel Disease

OBJECTIVE: To investigate the olfactory/gustatory functions of patients with inflammatory bowel disease (IBD) by smell/taste tests, and to determine if disease activity or medication might influence the olfactory/gustatory functions of patients. PATIENTS AND METHODS: In total, 59 IBD patients (37 Cr...

Descripción completa

Detalles Bibliográficos
Autores principales: Steinbach, Silke, Reindl, Wolfgang, Dempfle, Astrid, Schuster, Anna, Wolf, Petra, Hundt, Walter, Huber, Wolfgang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3783456/
https://www.ncbi.nlm.nih.gov/pubmed/24086282
http://dx.doi.org/10.1371/journal.pone.0073454
_version_ 1782285669816598528
author Steinbach, Silke
Reindl, Wolfgang
Dempfle, Astrid
Schuster, Anna
Wolf, Petra
Hundt, Walter
Huber, Wolfgang
author_facet Steinbach, Silke
Reindl, Wolfgang
Dempfle, Astrid
Schuster, Anna
Wolf, Petra
Hundt, Walter
Huber, Wolfgang
author_sort Steinbach, Silke
collection PubMed
description OBJECTIVE: To investigate the olfactory/gustatory functions of patients with inflammatory bowel disease (IBD) by smell/taste tests, and to determine if disease activity or medication might influence the olfactory/gustatory functions of patients. PATIENTS AND METHODS: In total, 59 IBD patients (37 Crohn's disease (CD) and 22 ulcerative colitis (UC) patients) were studied using “Sniffin' sticks” and “taste strips” for olfactory and gustatory tests, respectively, and compared to healthy controls and published normative data. RESULTS: Among IBD (CD and UC) patients, the values for odor threshold, but not for odor identification or discrimination, were significantly lower than that of the normative data. Further, these patients showed lower values than the normative taste values and the control group for all tastes, except sour; 57.6% of the IBD patients were hyposmic, while 30.5% were hypogeusic. Subjective self-assessments showed that the patients were not aware of their reduced olfactory/gustatory functions. There were no relevant differences in taste and smell abilities between the CD and UC patients. Disease activity and treatment did not influence the olfactory/gustatory functions. CONCLUSION: IBD (CD and UC) patients exhibited significant reductions in the olfactory and gustatory functions. Therefore, patients should be tested by smell/taste tests, in order to be adequately informed of their olfactory/gustatory functions and provided an understanding of how to overcome their limitations, and thus improve their quality of life.
format Online
Article
Text
id pubmed-3783456
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-37834562013-10-01 Smell and Taste in Inflammatory Bowel Disease Steinbach, Silke Reindl, Wolfgang Dempfle, Astrid Schuster, Anna Wolf, Petra Hundt, Walter Huber, Wolfgang PLoS One Research Article OBJECTIVE: To investigate the olfactory/gustatory functions of patients with inflammatory bowel disease (IBD) by smell/taste tests, and to determine if disease activity or medication might influence the olfactory/gustatory functions of patients. PATIENTS AND METHODS: In total, 59 IBD patients (37 Crohn's disease (CD) and 22 ulcerative colitis (UC) patients) were studied using “Sniffin' sticks” and “taste strips” for olfactory and gustatory tests, respectively, and compared to healthy controls and published normative data. RESULTS: Among IBD (CD and UC) patients, the values for odor threshold, but not for odor identification or discrimination, were significantly lower than that of the normative data. Further, these patients showed lower values than the normative taste values and the control group for all tastes, except sour; 57.6% of the IBD patients were hyposmic, while 30.5% were hypogeusic. Subjective self-assessments showed that the patients were not aware of their reduced olfactory/gustatory functions. There were no relevant differences in taste and smell abilities between the CD and UC patients. Disease activity and treatment did not influence the olfactory/gustatory functions. CONCLUSION: IBD (CD and UC) patients exhibited significant reductions in the olfactory and gustatory functions. Therefore, patients should be tested by smell/taste tests, in order to be adequately informed of their olfactory/gustatory functions and provided an understanding of how to overcome their limitations, and thus improve their quality of life. Public Library of Science 2013-09-25 /pmc/articles/PMC3783456/ /pubmed/24086282 http://dx.doi.org/10.1371/journal.pone.0073454 Text en © 2013 Steinbach et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Steinbach, Silke
Reindl, Wolfgang
Dempfle, Astrid
Schuster, Anna
Wolf, Petra
Hundt, Walter
Huber, Wolfgang
Smell and Taste in Inflammatory Bowel Disease
title Smell and Taste in Inflammatory Bowel Disease
title_full Smell and Taste in Inflammatory Bowel Disease
title_fullStr Smell and Taste in Inflammatory Bowel Disease
title_full_unstemmed Smell and Taste in Inflammatory Bowel Disease
title_short Smell and Taste in Inflammatory Bowel Disease
title_sort smell and taste in inflammatory bowel disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3783456/
https://www.ncbi.nlm.nih.gov/pubmed/24086282
http://dx.doi.org/10.1371/journal.pone.0073454
work_keys_str_mv AT steinbachsilke smellandtasteininflammatoryboweldisease
AT reindlwolfgang smellandtasteininflammatoryboweldisease
AT dempfleastrid smellandtasteininflammatoryboweldisease
AT schusteranna smellandtasteininflammatoryboweldisease
AT wolfpetra smellandtasteininflammatoryboweldisease
AT hundtwalter smellandtasteininflammatoryboweldisease
AT huberwolfgang smellandtasteininflammatoryboweldisease